Co-Diagnostics, Inc. (CODX) SEC filings

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$0.28−0.01 (-3.78%)

Close on Nov 11, 2026Market cap $1.74MP/E –Yield –

SEC filings

40 of Co-Diagnostics's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 10, 2026	SEC EDGAR
Current report	8-K	Nov 10, 2026	Nov 10, 2026	SEC EDGAR
Proxy statement	DEF 14A	Oct 26, 2026	Oct 26, 2026	SEC EDGAR
Current report	8-K	Oct 14, 2026	Oct 15, 2026	SEC EDGAR
Current report	8-K	Oct 9, 2026	Oct 13, 2026	SEC EDGAR
Current report	8-K	Sep 30, 2026	Oct 5, 2026	SEC EDGAR
Current report	8-K	Sep 3, 2026	Sep 25, 2026	SEC EDGAR
Current report	8-K	Sep 16, 2026	Sep 16, 2026	SEC EDGAR
Current report	8-K	Sep 16, 2026	Sep 16, 2026	SEC EDGAR
Current report	8-K	Aug 25, 2026	Sep 15, 2026	SEC EDGAR
Current report	8-K	Sep 2, 2026	Sep 4, 2026	SEC EDGAR
Current report	8-K	Sep 3, 2026	Sep 4, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 13, 2026	SEC EDGAR
Current report	8-K	Aug 13, 2026	Aug 13, 2026	SEC EDGAR
Current report	8-K	Jul 30, 2026	Jul 31, 2026	SEC EDGAR
Current report	8-K	Jul 27, 2026	Jul 27, 2026	SEC EDGAR
Proxy statement	DEF 14A	Jul 21, 2026	Jul 21, 2026	SEC EDGAR
Current report	8-K	May 19, 2026	May 21, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 14, 2026	SEC EDGAR
Current report	8-K	May 14, 2026	May 14, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 31, 2026	SEC EDGAR
Current report	8-K	Mar 31, 2026	Mar 31, 2026	SEC EDGAR
Current report	8-K	Mar 9, 2026	Mar 10, 2026	SEC EDGAR
Current report	8-K	Jan 7, 2026	Jan 13, 2026	SEC EDGAR
Current report	8-K	Dec 29, 2025	Dec 30, 2025	SEC EDGAR
Current report	8-K	Dec 5, 2025	Dec 5, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 13, 2025	SEC EDGAR
Current report	8-K	Nov 13, 2025	Nov 13, 2025	SEC EDGAR
Proxy statement	DEF 14A	Nov 10, 2025	Nov 10, 2025	SEC EDGAR
Current report	8-K	Oct 28, 2025	Oct 29, 2025	SEC EDGAR
Current report	8-K	Sep 30, 2025	Oct 20, 2025	SEC EDGAR
Current report	8-K	Sep 30, 2025	Sep 30, 2025	SEC EDGAR
Current report	8-K	Sep 17, 2025	Sep 18, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 14, 2025	SEC EDGAR
Current report	8-K	Aug 14, 2025	Aug 14, 2025	SEC EDGAR
Current report	8-K	Jul 10, 2025	Jul 11, 2025	SEC EDGAR
Current report	8-K	May 28, 2025	May 29, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 8, 2025	SEC EDGAR
Current report	8-K	May 8, 2025	May 8, 2025	SEC EDGAR
Current report	8-K	Apr 25, 2025	Apr 28, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Co-Diagnostics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Jan 2, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CODX.

Compare: CODX vs SINT · CODX vs INBS · CODX vs PETV · CODX vs FEMY · CODX vs HRGN

Revenue growth69.1% · median 36.5%

Gross margin20.3% · median 59.5%

Operating margin-5614.3% · median -683.3%

Net margin-5527.6% · median -511.8%

Company	Revenue	Growth
INBS	$4.50M	+36.5%
SINT	$3.31M	+160.8%
FEMY	$2.30M	+21.9%
PETV	$1.18M	-9.5%
HRGN	$982.00K	+44.6%
CODX	$858.89K	+69.1%

Company

Next earnings (est.): Mar 30, 2027, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 115
Held by institutions: 9.5%
Auditor: Tanner LLP
SEC CIK: 1692415

Advertisement
300 × 250

See a number that looks wrong?